JP2010512169A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010512169A5 JP2010512169A5 JP2009541546A JP2009541546A JP2010512169A5 JP 2010512169 A5 JP2010512169 A5 JP 2010512169A5 JP 2009541546 A JP2009541546 A JP 2009541546A JP 2009541546 A JP2009541546 A JP 2009541546A JP 2010512169 A5 JP2010512169 A5 JP 2010512169A5
- Authority
- JP
- Japan
- Prior art keywords
- oligonucleotide
- seq
- solvent
- nucleoside
- coupling solution
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US86958806P | 2006-12-12 | 2006-12-12 | |
| US60/869,588 | 2006-12-12 | ||
| PCT/US2007/087183 WO2008073960A2 (en) | 2006-12-12 | 2007-12-12 | Oligonucleotides containing high concentrations of guanine monomers |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2010512169A JP2010512169A (ja) | 2010-04-22 |
| JP2010512169A5 true JP2010512169A5 (enExample) | 2011-03-24 |
| JP5389662B2 JP5389662B2 (ja) | 2014-01-15 |
Family
ID=39456527
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009541546A Active JP5389662B2 (ja) | 2006-12-12 | 2007-12-12 | 高濃度のグアニン・モノマーを含有するオリゴヌクレオチド |
Country Status (7)
| Country | Link |
|---|---|
| US (3) | US8586728B2 (enExample) |
| EP (1) | EP2125854B1 (enExample) |
| JP (1) | JP5389662B2 (enExample) |
| CN (1) | CN101611048B (enExample) |
| AU (1) | AU2007333147B2 (enExample) |
| CA (1) | CA2671873C (enExample) |
| WO (1) | WO2008073960A2 (enExample) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE102008063490B4 (de) * | 2008-12-17 | 2023-06-15 | Merck Patent Gmbh | Organische Elektrolumineszenzvorrichtung und Verfahren zum Einstellen des Farbortes einer weiß emittierenden Elektrolumineszenzvorrichtung |
| WO2012059510A1 (en) | 2010-11-02 | 2012-05-10 | Girindus America, Inc. | Back pressure control during solid-phase synthesis on polymeric supports |
| US10040048B1 (en) | 2014-09-25 | 2018-08-07 | Synthego Corporation | Automated modular system and method for production of biopolymers |
| HUE053145T2 (hu) | 2014-12-31 | 2021-06-28 | Checkmate Pharmaceuticals Inc | Kombinált tumor immunterápia |
| WO2017005818A1 (en) * | 2015-07-08 | 2017-01-12 | Kuros Biosciences Ag | Guanine-rich oligonucleotides |
| JPWO2017111137A1 (ja) | 2015-12-22 | 2018-10-18 | 味の素株式会社 | オリゴヌクレオチドの製造方法 |
| US20190046638A1 (en) | 2016-04-01 | 2019-02-14 | Checkmate Pharmaceuticals, Inc. | Fc RECEPTOR-MEDIATED DRUG DELIVERY |
| EP3681637A4 (en) | 2017-09-11 | 2021-06-02 | Synthego Corporation | SYSTEM AND PROCEDURE FOR BIOPOLYMER SYNTHESIS |
| WO2019080704A1 (zh) * | 2017-10-25 | 2019-05-02 | 深圳华大生命科学研究院 | 用于核酸合成的微流控芯片 |
| WO2019160866A2 (en) | 2018-02-13 | 2019-08-22 | Checkmate Pharmaceuticals, Inc. | Compositions and methods for tumor immunotherapy |
| BR112020020479A2 (pt) | 2018-04-09 | 2021-01-12 | Checkmate Pharmaceuticals | Empacotamento de oligonucleotídeos em partículas similares a vírus |
| US12049620B2 (en) * | 2018-09-11 | 2024-07-30 | Amgen Inc. | Purification methods for guanine-rich oligonucleotides |
| US12655470B2 (en) | 2018-10-30 | 2026-06-16 | Toray Industries, Inc. | Inhibitor of non-specific binding of nucleic acid, hybridization reagent and nucleic acid hybridization method |
| CN112969527A (zh) * | 2018-11-08 | 2021-06-15 | 深圳华大生命科学研究院 | 一种微流控芯片及其制备方法和dna合成方法 |
| US12202848B2 (en) * | 2019-10-18 | 2025-01-21 | Fujifilm Wako Pure Chemical Corporation | Phosphoramidite activator |
| US20230322842A1 (en) * | 2020-04-14 | 2023-10-12 | Sumitomo Chemical Company, Limited | Composition containing nucleic acid oligomer |
| CN114425443B (zh) * | 2020-10-29 | 2025-10-31 | 江苏金斯瑞生物科技有限公司 | 一种寡核苷酸合成催化剂 |
| GB202114688D0 (en) | 2021-10-14 | 2021-12-01 | Exactmer Ltd | Solution phase polymer synthesis |
| GB202414228D0 (en) | 2024-09-27 | 2024-11-13 | Exactmer Ltd | Solvent recycling in a liquid-phase process for preparing a defined monomoer sequence polymer |
Family Cites Families (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1984004749A1 (en) | 1983-06-01 | 1984-12-06 | Beckman Instruments Inc | Novel preparation of nucleoside phosphoramidite intermediates |
| US20030050263A1 (en) | 1994-07-15 | 2003-03-13 | The University Of Iowa Research Foundation | Methods and products for treating HIV infection |
| WO1998016247A1 (en) | 1996-10-11 | 1998-04-23 | The Regents Of The University Of California | Immunostimulatory polynucleotide/immunomodulatory molecule conjugates |
| AU7350798A (en) | 1997-04-29 | 1998-11-24 | Universiteit Utrecht | Corona virus-like particles as tools for vaccination and therapy |
| AU750702B2 (en) | 1997-05-01 | 2002-07-25 | Chiron Corporation | Use of virus-like particles as adjuvants |
| US6171591B1 (en) | 1997-12-08 | 2001-01-09 | Pentamer Pharmaceuticals, Inc. | Recombinant nodavirus compositions and methods |
| US6541438B1 (en) | 1998-05-01 | 2003-04-01 | The Procter & Gamble Company | Laundry detergent and/or fabric care compositions comprising a modified cellulase |
| WO2000023955A1 (en) | 1998-10-21 | 2000-04-27 | The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services | Virus-like particles for the induction of autoantibodies |
| MXPA01005389A (es) | 1998-11-30 | 2003-03-27 | Cytos Biotechnology Ag | Presentacion molecular ordenada de antigenos, metodos de preparacion y uso. |
| JP2003520568A (ja) | 1999-02-02 | 2003-07-08 | バイオカシェ ファーマシューティカルズ， インコーポレイテッド | 高度な抗原提示プラットフォーム |
| WO2000050006A2 (en) | 1999-02-26 | 2000-08-31 | Chiron Corporation | Microemulsions with adsorbed macromoelecules and microparticles |
| WO2001022972A2 (en) | 1999-09-25 | 2001-04-05 | University Of Iowa Research Foundation | Immunostimulatory nucleic acids |
| US6949520B1 (en) | 1999-09-27 | 2005-09-27 | Coley Pharmaceutical Group, Inc. | Methods related to immunostimulatory nucleic acid-induced interferon |
| IL148844A0 (en) | 1999-09-27 | 2002-09-12 | Coley Pharm Group Inc | Methods related to immunostimulatory nucleic acid-induced interferon |
| ATE454901T1 (de) | 1999-10-13 | 2010-01-15 | Novartis Vaccines & Diagnostic | Verfahren zur erhaltung zellimmuneantworten gegen proteinen |
| WO2001038358A2 (en) | 1999-11-24 | 2001-05-31 | Chiron Corporation | Hbv/hcv virus-like particle |
| AT409085B (de) | 2000-01-28 | 2002-05-27 | Cistem Biotechnologies Gmbh | Pharmazeutische zusammensetzung zur immunmodulation und herstellung von vakzinen |
| EP1261366A4 (en) | 2000-02-24 | 2003-06-18 | Univ Leland Stanford Junior | ADJUVANT TREATMENT BY IN VIVO ACTIVATION OF DENDRITIC CELLS |
| AU2002248185A1 (en) | 2000-12-14 | 2002-07-16 | Coley Pharmaceutical Group, Inc. | Inhibition of angiogenesis by nucleic acids |
| US20030050268A1 (en) | 2001-03-29 | 2003-03-13 | Krieg Arthur M. | Immunostimulatory nucleic acid for treatment of non-allergic inflammatory diseases |
| EP1425040A2 (en) | 2001-09-14 | 2004-06-09 | Cytos Biotechnology AG | In vivo activation of antigen presenting cells for enhancement of immune responses induced by virus like particles |
| EP1450856B1 (en) | 2001-09-14 | 2009-11-11 | Cytos Biotechnology AG | Packaging of immunostimulatory cpg into virus-like particles: method of preparation and use |
| US7524950B2 (en) * | 2001-10-31 | 2009-04-28 | Agilent Technologies, Inc. | Uses of cationic salts for polynucleotide synthesis |
| ATE489969T1 (de) | 2002-06-20 | 2010-12-15 | Cytos Biotechnology Ag | Verpackte virusartige partikel in kombination mit cpg zur verwendung als adjuvantien mit allergenen. herstellungsverfahren und verwendung |
| CN101675993A (zh) | 2003-03-26 | 2010-03-24 | 赛托斯生物技术公司 | Melan-a肽类似物-病毒样颗粒偶联物 |
| US20060210588A1 (en) | 2003-03-26 | 2006-09-21 | Cytos Biotechnology Ag | Hiv-peptide-carrier-conjugates |
| US7537767B2 (en) | 2003-03-26 | 2009-05-26 | Cytis Biotechnology Ag | Melan-A- carrier conjugates |
| AU2004255470B2 (en) | 2003-07-10 | 2010-08-19 | Cytos Biotechnology Ag | Packaged virus-like particles |
| WO2005014110A1 (en) * | 2003-07-22 | 2005-02-17 | Cytos Biotechnology Ag | Cpg-packaged liposomes |
| JP4628686B2 (ja) | 2004-02-25 | 2011-02-09 | 独立行政法人科学技術振興機構 | ホスホロアミダイトを含む３’末端ヌクレオシドユニット |
| WO2006029023A2 (en) * | 2004-09-02 | 2006-03-16 | Isis Pharmaceuticals, Inc. | Polymeric beads for oligonucleotide synthesis |
| NZ554387A (en) | 2004-09-21 | 2009-09-25 | Cytos Biotechnology Ag | Virus-like particles comprising a fusion protein of the coat protein of AP205 and an antigenic polypeptide |
| AU2006325225B2 (en) | 2005-12-14 | 2013-07-04 | Cytos Biotechnology Ag | Immunostimulatory nucleic acid packaged particles for the treatment of hypersensitivity |
-
2007
- 2007-12-12 CN CN2007800498509A patent/CN101611048B/zh active Active
- 2007-12-12 AU AU2007333147A patent/AU2007333147B2/en active Active
- 2007-12-12 CA CA2671873A patent/CA2671873C/en active Active
- 2007-12-12 WO PCT/US2007/087183 patent/WO2008073960A2/en not_active Ceased
- 2007-12-12 US US11/954,511 patent/US8586728B2/en active Active
- 2007-12-12 JP JP2009541546A patent/JP5389662B2/ja active Active
- 2007-12-12 EP EP07865549.5A patent/EP2125854B1/en active Active
-
2013
- 2013-10-15 US US14/054,068 patent/US20140200338A1/en not_active Abandoned
-
2015
- 2015-06-23 US US14/748,045 patent/US9914746B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR102640410B1 (ko) | 표면-결합 올리고뉴클레오타이드의 화학적 절단 및 탈보호를 위한 조성물 및 방법 | |
| TW393513B (en) | Enhanced triple-helix and double-helix formation with oligomers containing modified pyrimidines | |
| US5594121A (en) | Enhanced triple-helix and double-helix formation with oligomers containing modified purines | |
| JP2005518803A5 (enExample) | ||
| JP2005524393A5 (enExample) | ||
| JP2005517452A5 (enExample) | ||
| JP2011135823A (ja) | オリゴヌクレオチドプローブ及びその利用 | |
| JP6732744B2 (ja) | ルテニウム触媒作用によるアゾベンゾール類からのビフェニルアミン類の製造方法 | |
| CN101475505A (zh) | 甲灭酸的制备方法 | |
| CN110590886A (zh) | 修饰核苷、核苷酸和核酸聚合物及其制备方法与应用 | |
| JP2007533727A5 (enExample) | ||
| CN115197289A (zh) | 用于测序的核苷酸类似物 | |
| JP6920689B2 (ja) | 可視光域で光架橋可能な光応答性ヌクレオチドアナログ | |
| Seela et al. | Synthesis of 4‐Substituted 1H‐Benzimidazole 2′‐Deoxyribonucleosides and Utility of the 4‐Nitro Compound as Universal Base | |
| JP7298866B2 (ja) | 核酸合成用固相担体及びそれを用いた核酸の製造方法 | |
| JP2020507346A5 (enExample) | ||
| JP2008541708A (ja) | ねじれたインターカレーティング核酸（ｔｉｎａ）を用いた、フーグスティーン型の三重鎖および二重鎖の安定でそして選択的な形成、ならびにｔｉｎａの調製法 | |
| JP2009507478A5 (enExample) | ||
| JP2008530269A5 (enExample) | ||
| JP2024522217A5 (enExample) | ||
| CN100513402C (zh) | 2-氧代-1-苯基-3-氧杂双环[3.1.0]己烷的制造方法 | |
| Jessen et al. | Design of an Intercalating Linker Leading to the First Efficiently 5′, 5′‐Linked Alternate‐Strand Hoogsteen Triplex with High Stability and Specificity | |
| JP4665758B2 (ja) | チオヌクレオシド−ｓ−ニトロシル誘導体 | |
| Kumar et al. | C5-alkynyl-functionalized α-L-LNA: Synthesis, thermal denaturation experiments and enzymatic stability | |
| Andersen et al. | Nucleic acid secondary structures containing the double-headed nucleoside 5′(S)-C-(2-(thymin-1-yl) ethyl) thymidine |